The synthesis and antibacterial activity of totarol derivatives. Part 3: modification of ring-B

Bioorganic and Medicinal Chemistry

Volumn 8, Issue 7, 2000, Pages 1663-1675

  Evans, Gary B ^a   Furneaux, Richard H ^a   Gainsford, Graeme J ^a   Murphy, Michael P ^b  

^a CALLAGHAN INNOVATION   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; TOTAROL DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CONFORMATION; DRUG RESISTANCE; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STREPTOCOCCUS PNEUMONIA; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; ATP SYNTHETASE COMPLEXES; BIOLOGICAL AVAILABILITY; CARBONYL CYANIDE P-TRIFLUOROMETHOXYPHENYLHYDRAZONE; CELL MEMBRANE PERMEABILITY; DITERPENES; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ENTEROCOCCUS FAECALIS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; INHIBITORY CONCENTRATION 50; INTRACELLULAR MEMBRANES; IONOPHORES; KLEBSIELLA PNEUMONIAE; LIVER; MITOCHONDRIA; MULTIENZYME COMPLEXES; OXIDATIVE PHOSPHORYLATION; PHOSPHOTRANSFERASES (PHOSPHATE GROUP ACCEPTOR); PLANT EXTRACTS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STRUCTURE-ACTIVITY RELATIONSHIP; SUCCINIC ACID; UNCOUPLING AGENTS;

ENTEROCOCCUS FAECALIS; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0033920245     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(00)00096-1     Document Type: Article

References (28)

1. Lien E.J., Hansch C., Anderson S.M. J. Med. Chem. 11:1968;430.
2. Kobayashi K., Nishino C., Fukushima M., Shiobara Y., Kodama M. Agric. Biol. Chem. 52:1988;77.
3. For part I, see Evans, G. B.; Furneaux, R. H.; Gravestock, M. B.; Lynch, G. P.; Scott, G. K. Bioorg. Med. Chem. 1999, 7, 1953.
4. For part II, see Evans, G. B.; Furneaux, R. H. Bioorg. Med. Chem. 2000, 8, 1653.
5. Short, W. F.; Stromberg, H. J. Chem. Soc. 1937, 516.
6. Cambie R.C., Hayward R.C. Aust. J. Chem. 27:1974;2001.
7. Chow Y.L., Erdtman H. Acta Chem. Scand. 16:1962;1305.
8. Chow Y.L., Erdtman H. Acta Chem. Scand. 14:1960;1852.
9. Brieskorn C.H., Fuchs A., Bredenberg J.B-son, McChesney J.D., Wenker E. J. Org. Chem. 29:1964;2293.
10. Baker K.M., Davis B.R. Tetrahedron. 25:1969;2487.
11. Adegoke, E. A.; Ojechi, P.; Taylor, D. A. H. J. Chem. Soc. 1965, 415.
12. Kubo I., Muroi H., Himejima M. J. Nat. Prod. 55:1992;1436.
13. Cutfield, J. F.; Waters, T. N.; Clark, G. R. J. Chem Soc., Perkin Trans. 2 1974, 150.
14. Matsumoto T., Endo Y., Okimoto M. Bull. Chem. Soc. Jpn. 56:1983;2013.
15. Matsumoto T., Imai S., Yoshinari T. Bull. Chem. Soc. Jpn. 60:1987;2435.
16. Geiwiz J., Haslinger E. Helv. Chim. Acta. 78:1995;818.
17. Cremer D., Pople J.A. J. Am. Chem. Soc. 97:1975;1354.
18. Biosym Technologies Program Discover® 2.97 using CVFF Forcefield; Biosym Technologies Inc., San Diego, 1993.
19. Perrin D.D., Armarego W.L.F. Purification of Laboratory Chemicals. 3rd ed. 1988;Pergamon, Oxford.
20. Finucane, B. W.; Thomson, J. B., J. Chem Soc., Chem Commun. 1969, 1220.
21. Hodges, R. J. Chem. Soc. 1961, 4247.
22. Cambie R.C., Gallagher R.T. Tetrahedron. 24:1968;4631.
23. Chappell, J. B.; Hansford, R. G. In Subcellular Components: Preparation and Fractionation; Birnie, G. D., Ed.; Butterworths: London, 1972; pp 77-91.
24. Gornall A.G., Bardawill C.J., David M.M. J. Biol. Chem. 177:1949;751.
25. Reynafarje B., Costa L.E., Lehninger A.L. Anal. Biochem. 145:1985;406.
26. International Tables for Crystallography; Hahn, T., Ed.; Kluwer Academic: Dordrecht, 1995; Vol. A.
27. Sheldrick G.M. SHELXS-86 Program for Crystal Structure Determination. 1986;Institute for Anorganische Chemie der Universitat, Gottingen, Germany.
28. Sheldrick G.M. SHELXL-93 Program for Refinement of Crystal Structures. 1993;University of Gottingen, Gottingen, Germany.